LY300164
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LY300164, covering 2008-03-04 to 2008-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Study of LY300164 for the Treatment of Parkinson's Disease [Phase 2]